NCT01301599

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Comparison Between Alpha Blocker Monotherapy and 5-alpha-reductase Inhibitor Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 308 (actual)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: Male
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to investigate the comparison between alpha blocker monotherapy and 5-alpha-reductase inhibitor monotherapy following combination therapy in benign prostatic hyperplasia.

Conditions

• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	combination therapy	alpha blocker and 5-alpha-reductase inhibitor medication
DRUG	alpha blocker monotherapy	alpha blocker monotherapy group
DRUG	5 alpha reductase inhibitor monotherapy	5 alpha reductase inhibitor monotherapy

Timeline

• Start date: 2011-01-01
• Primary completion: 2013-07-01
• Completion: 2013-12-01
• First posted: 2011-02-23
• Last updated: 2019-12-02

Locations

1 site across 1 country: South Korea